Metrifonate improves associative learning and retention in aging rabbits

Behavioral Neuroscience

Volumn 111, Issue 5, 1997, Pages 1031-1040

  Kronforst Collins, M A ^c   Schmidt, B ^a   Moriearty, P L ^c   Disterhoft, J F ^b  

^a BAYER AG   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

METRIFONATE;

AGING; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; DOSE RESPONSE; DRUG EFFECT; EYELID REFLEX; LONG TERM MEMORY; NONHUMAN; RABBIT; STATE DEPENDENT LEARNING;

ACETYLCHOLINESTERASE; AGING; ANIMALS; ASSOCIATION LEARNING; CHOLINESTERASE INHIBITORS; CONDITIONING, CLASSICAL; CONDITIONING, EYELID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIPPOCAMPUS; RABBITS; RETENTION (PSYCHOLOGY); TREATMENT OUTCOME; TRICHLORFON;

EID: 0030813611     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.111.5.1031     Document Type: Article

References (73)

1. Akase, E., Thompson, L. T., & Disterhoft, J. F. (1994). A system for quantitative analysis of associative learning: Part 2. Real-time software for MS-DOS microcomputers. Journal of Neuroscience Methods, 54, 119-130.
2. Bartus, R., Dean, R., Beer, B., & Lippa, A. (1982, July 30). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-416.
3. Bassant, M. H., Jazat-Poindessous, F., & Lamour, Y. (1996). Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats. Journal of Cerebral Blood Flow and Metabolism, 16, 1014-1025.
4. Becker, R. E., Colliver, J., Elble, R., Feldman, E., Giacobini, E., Kumar, V., Markwell, S., Moriearty, P., Parks, R., Shillcutt, S. D., Unni, L., Vicari, S., Womack, C., & Zec, R. F. (1990). Effects of metrifonate, a long-acting cholinesterase inhibitor, in Alzheimer disease: Report of an open trial. Drug Development Research, 19, 425-434.
5. Becker, R. E., Moriearty, P., Surbeek, R., Unni, L., Varney, A., & Vicari, S. K. (1994). Second and third generation cholinesterase inhibitors: Clinical aspects. In E. Giacobini & R. Becker (Eds.), Alzheimer's disease: Therapeutic strategies (pp. 172-178). Boston: Birkhauser.
6. Becker, R. E., Moriearty, P., & Unni, L. (1991). The second generation of cholinesterase inhibitors: Clinical and pharmacological effects. In R. E. Becker & E. Giacobini (Eds.), Cholinergic basis for Alzheimer therapy (pp. 263-296). Boston: Birkhauser.
7. Berger, T. W., Rinaldi, P., Weisz, D. J., & Thompson, R. F. (1983). Single unit analysis of different hippocampal cell types during classical conditioning of the rabbit nictitating membrane response. Journal of Neurophysiology, 59, 1197-1219.
8. Berger, T. W., & Thompson, R. F. (1978). Identification of pyramidal cells as critical in hippocampal neuronal plasticity during learning. Proceedings of the National Academy of Sciences. USA, 75, 1572-1578.
9. Bignami, G., Rosi, N., Michalek, H., Milosevic, M., & Gatti, G. L. (1975). Behavioral toxicity of anticholinesterasc agents: Method ological, neurochemical, and neuropsychological aspects. In B. Weiss & V. G. Laties (Eds.), Behavioral toxicology (pp. 155-215). New York: Plenum Press.
10. Bjorkland, M., Jakala, P., Schmidt, B., Riekkinen, M., Koivisto, E., & Riekkinen, P., Jr. (1996). An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats. NeuroReport, 7, 1097-1101.
11. Blitzer, R. D., Gil, O., & Landau, E. M. (1990). Cholinergic stimulation enhances long-term potentiation in the CA1 region of rat hippocampus. Neuroscience letters, 119, 207-210.
12. Blokland, A., Hinz, F., & Schmidt, B. (1995). Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: Evaluation of the efficacy/safety profile in rats. Drug Development Research, 36, 166-179.
13. Burgard, E. C., & Sarvey, J. M. (1990). Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neuroscience Letters, 116, 34-39.
14. Coyle, J. T., Price, D. L., & DeLong, M. R. (1982). Brain mechanisms in Alzheimer's disease. Hospital Practice, 17, 55-63.
15. Coyle, J. T., Price, D. L., & DeLong, M. R. (1983, March 11). Alzheimer's disease: A disorder of cortical cholinergic innervation. Science, 219, 1184-1190.
16. Cummings, J., Bieber, F., Mas, J., Orazem, J., & Gulanski, B. (1996). Metrifonate in Alzheimer's disease-results of a dose-finding study. Neurobiology of Aging. 17(Suppl. 4), S153-S154.
17. Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., & Hoover, T. M. (1992). A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. New England Journal of Medicine, 327, 1253-1259.
18. Dawson, G. R., & Iversen, S. D. (1993). The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behavioral Brain Research, 57, 143-153.
19. Disterhoft, J. F., Kwan, H. H., & Lo, W. D. (1977). Nictitating membrane conditioning to tone in the immobilized albino rabbit. Brain Research, 137, 127-143.
20. Disterhoft, J. F., Thompson, L. T., & Mover, J. R., Jr. (1994). Cellular mechanisms of associative learning in the hippocampus. In J. Delacour (Ed.), The memory system of the brain (pp. 431-492). Singapore: World Scientific Publishing.
21. Durkin, M., Prescott, L., Furchtgott, E., Cantor, J., & Powell, D. A. (1993). Concomitant eyeblink and heart rate classical conditioning in young, middle-aged, and elderly human subjects. Psychology of Aging, 8, 571-581.
22. Eichenbaum, H., Otto, T., & Cohen, N. J. (1992). The hippocampus - What does it do? Behavioral and Neural Biology, 57, 2-36.
23. Fishbein, H. D., & Gormezano, I. (1966). Effects of differential instructions, differential payoffs, and the presence or absence of feedback on the percentage, latency, and amplitude of the conditioned eyelid response. Journal of Experimental Psychology, 71, 535-538.
24. Geinisman, Y., deToledo-Morrell, L., Morrell, F., & Heller, R. E. (1995). Hippocampal markers of age-related memory dysfunction: Behavioral, electrophysiological, and morphological perspectives. Progress in Neurobiology 45, 223-252.
25. Giacobini, E., & Cuadra, G. (1994). Second and third generation cholinesterase inhibitors: from preclinical studies to clinical efficacy. In E. Giacobini & R. Becker (Eds.), Alzheimer's disease: Therapeutic strategies (pp. 155-171). Boston: Birkhauser.
26. Gormezano, I., Schneiderman, N., Deaux, F., & Fuentes, I. (1962, October 5). Nictitating membrane: Classical conditioning and extinction in the albino rabbit. Science, 138, 33-34.
27. Hagan, J. J., & Morris, R. G. M. (1988). The cholinergic hypothesis of memory: A review of animal experiments. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.), Psychopharmacology of the aging nervous system. Handbook of Psychopharmacology 20 (pp. 237-323). New York: Plenum Press.
28. Hallak, M., & Giacobini, E. (1987). A comparison of the effects of two inhibitors of brain cholinesterase. Neuropharmacology, 26, 521-530.
29. Hallak, M., & Giacobini, E. (1989). Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology, 28, 199-206.
30. Harvey, J. A., Gormezano, I., & Cool-Hauser, V. A. (1983). Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit's nictitating membrane response. Journal of Pharmaceutical and Experimental Therapeutics, 225, 42-49.
31. Hasselmo, M. E., Anderson, B. P., & Bower, J. M. (1992). Cholinergic modulation of conical associative memory function. Journal of Neurophysiology, 67, 1230-1246.
32. Hasselmo, M. E., & Barkai, E. (1995). Cholinergic modulation of activity-dependent synaptic plasticity in the piriform cortex and associative memory function in a network biophysical simulation. Journal of Neuroscience, 15, 6592-6604.
33. Hinz, V. C., Blokland, A., van der Staay, F., Geben, I., Schuurman, T., & Schmidt, B. H. (1996). Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents. Drug Development Research, 38, 31-42.
34. Hinz, V. C., Grewig, S., & Schmidt, B. H. (1996). Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochemical Research, 21, 331-337.
35. Huerta, P. T., & Lisman, J. E. (1994). Heightened synaptic plasticity of hippocampal CA1 neurons during the cholinergically induced rhythmic state. Nature, 364, 723-725.
36. Jaen, J. C., & Davis, R. E. (1993). Cholinergic therapies for Alzheimer's disease: Acetylcholinesterase inhibitors of current clinical interest. Current Opinion on Investigational Drugs, 2, 363-377.
37. Kim, J. J., Clark, R. E., & Thompson, R. F. (1995). Hippocampectomy impairs the memory of recently, but not remotely, acquired trace eyeblink conditioned responses. Behavioral Neuroscience, 109, 195-203.
38. Knapp, M. J., Knopman, D. S., Solomon, P. R., Pendlebury, W. W., Davis, C. S., & Gracon, S. I. (1994). A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. Journal of the American Medical Association, 271, 985-991.
39. Kronforst-Collins, M. A., Moriearty, P. L., Ralph, M., Becker, R. E., Schmidt. B., Thompson, L. T., & Disterhoft, J. F. (1997). Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits. Pharmacology Biochemistry and Behavior, 56, 103-110.
40. Levy, A., Brandeis, R., Treves, T. A., Meshulam, Y., Mwassi, F., Feiler, D., Wengier, A., Glikfeld, P., Grunwald, J., & Dachir, S. (1994). Transdermal physostigmine in the treatment of Alzheimer's disease. Alzheimer Disease and Associated Disorders, 8, 15-21.
41. Moore, J. W., Goodell, N. A., & Solomon, P. R. (1976). Central cholinergic blockade by scopolamine and habituation, classical conditioning, and latent inhibition of the rabbit's nictitating membrane response. Physiological Psychology, 4, 395-399.
42. Mori, F., Cuadra, G., & Giacobini, E. (1995). Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochemical Research, 20, 1081-1088.
43. Moyer, J. R., Jr., Deyo, R. A., & Disterhoft, J. F. (1990). Hippocampectomy disrupts trace eyeblink conditioning in rabbits. Behavioral Neuroscience, 104, 243-252.
44. Moyer, J. R., Jr., Thompson, L. T., & Disterhoft, J. F. (1996). Trace eyeblink conditioning increases CA1 excitability in a transient and learning-specific manner. Journal of Neuroscience, 16, 5536-5546.
45. Nordgren, I., Karlen, B., & Kimland, M. (1992). Metrifonate and tacrine: A comparative study on their effect on acetylcholine dynamics in mouse brain. Pharmacology and Toxicology, 71, 236-240.
46. Powell, D. A. (1979). Peripheral and central muscarinic cholinergic blockade: Effects on Pavlovian conditioning. Bulletin of the Psychiatric Society, 14, 161-164.
47. Powell, D. A., Buchanan, S. L., & Hernandez, L. L. (1981). Age-related changes in classical (Pavlovian) conditioning in the New Zealand albino rabbit. Experimental Aging Research, 7, 453-465.
48. Reiner, E., & Plestina, R. (1979). Regeneration of cholinesterase activities in humans and rats after inhibition by 0, 0-dimelhyl-2, 2-dichlorovinyl phosphate. Toxicology and Applied Pharmacology, 49, 451-454.
49. Riekkinen, P., Jr., Schmidt, B., Stefanski, R., Kuitunen, J., & Riekkinen, M. (1996). Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial-septumlesioned and aged rats. European Journal of Pharmacology, 309, 121-130.
50. Salvatierra, A. T., & Berry, S. D. (1989). Scopolamine disruption of septo-hippocampal activity and classical conditioning. Behavioral Neuroscience, 103, 715-721.
51. Sclar, D. A., & Skaer, T. L. (1992). Current concepts in the treatment of Alzheimer's disease. Clinical Therapeutics, 14, 2-10.
52. Soininen, H., Unni, L., & Shillcutt, S. (1990). Effect of acute and chronic cholineslerase inhibition on biogenic amines in rat brain. Neurochemical Research. 15, 1185-1190.
53. Solomon, P. R., Beal, M. F., & Pendlebury, W. W. (1988). Age-related disruption of classical conditioning: A model sys- tems approach to memory disorders. Neurobiology of Aging, 9, 535-546.
54. Solomon, P. R., Groccia-Ellison, M., Flynn, D., Mirak, J., Edwards, K. R., Dunehew, A., & Stanton, M. E. (1993). Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine. Behavioral Neuroscience, 107, 271-279.
55. Solomon, P. R., Groccia-Ellison, M., Levine, E., Blanchard, S., & Pendlebury, W. W. (1990). Do temporal relationships in conditioning change across the lifespan? Annals of the New York Academy of Sciences, 608, 212-232.
56. Solomon, P. R., Pomerleau, D., Bennett, L., James, J., & Morse, D. L. (1989). Acquisition of the classically conditioned eyeblink response in humans over the life span. Psychology of Aging, 4, 34-41.
57. Solomon, P. R., Solomon, S. D., VanderSchaaf, E. R., & Perry, H. E. (1983, April 15). Altered activity in the hippocampus is more detrimental than removal of the structure. Science, 220, 329-331.
58. Solomon, P. R., Vander Schaff, E., Thompson, R. F., & Weisz, D. J. (1986). Hippocampus and trace conditioning of the rabbit's classically conditioned nictitating membrane response. Behavioral Neuroscience, 100, 729-744.
59. Thompson, L. T., Moyer, J. R., Akase, E., & Disterhoft, J. F. (1994). A system of quantitative analysis of associative learning: Pan 1. Hardware interfaces with cross-species applications. Journal of Neuroscience Methods, 54, 109-117.
60. Thompson, L. T., Moyer, J. R., & Disterhoft, J. F. (1996a). Trace eyeblink conditioning in rabbits demonstrates heterogeneity of learning ability both between and within age groups. Neurobiology of Aging, 17, 619-629.
61. Thompson, L. T., Moyer, J. R., & Disterhoft, J. F. (1996b). Transient changes in excitability of rabbit CA3 neurons with a time-course appropriate to support memory consolidation. Journal of Neurophysiology, 76, 1836-1849.
62. Thompson, R. F., Berger, T. W., Cegavske, C. F., Patterson, M. M., Roemer, R. A., Teyler, T. A., & Young, R. A. (1976). The search for the engram. American Psychologist, 31, 209-227.
63. Thompson, R. F., & Krupa, D. J. (1994). Organization of memory traces in the mammalian brain. Annual Review of Neuroscience, 17, 519-549.
64. van der Staay, F. J., Hinz, V. C., & Schmidt, B. H. (1996a). Effects of metrifonate on escape and avoidance learning in young and aged rats. Behavioral Pharmacology, 7, 56-64.
65. van der Staay, F. J., Hinz, V. C., & Schmidt, B. H. (1996b). Effects of metrifonate, its transformation product dichlorvos, and other organophosphorous and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats. Journal of Pharmacology and Experimental Therapeutics, 278, 697-708.
66. Van Hoesen, G. W., & Solodkin, A. (1994). Cellular and systems neuroanatomical changes in Alzheimer's Disease. Annals of the New York Academy of Sciences, 747, 12-35.
67. Watkins, P. B., Zimmerman, H. J., Knapp, M. J., Gracon, S. I., & Lewis, K. W. (1994). Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. Journal of the American Medical Association, 271, 992-998.
68. Woodruff-Pak, D. S. (1988). Aging and classical conditioning: Parallel studies in rabbits and humans. Neurobiology of Aging, 9, 511-522.
69. Woodruff-Pak, D. S., Lavond, D. G., Logan, C. G., & Thompson, R. F. (1987). Classical conditioning in 3-, 30-, and 45-month-old rabbits: Behavioral learning and hippocampal unit activity. Neurobiology of Aging, 8, 101-108.
70. Woodruff-Pak, D. S., Li, Y. T., & Kem, W. R. (1994). A nicotinic agonist (GTS-21), eyeblink conditioning, and nicotinic receptor binding in rabbit brain. Brain Research, 645, 309-317.
71. Woodruff-Pak, D. S., Li, Y. T., Kazmi, A., & Kem, W. R. (1994). Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits. Behavioral Neuroscience, 108, 486-493.
72. Woodruff-Pak, D. S., Logan, D. G., & Thompson, R. (1990). Neurobiological substrates of classical conditioning across the life span. Annals of the New York Academy of Sciences, 608, 150-173.
73. Woodruff-Pak., D. S., & Thompson, R. F. (1988). Classical conditioning of the eyeblink response in the delay paradigm in adults aged 18-83 years. Psychology and Aging, 3, 219-229.